Retatrutide — Triple Agonist (GLP-1/GIP/Glucagon) for Advanced Metabolic Research
Retatrutide is a next-generation investigational peptide that acts as a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. As one of the most advanced metabolic research tools, Retatrutide represents the frontier of multi-target metabolic pharmacology and weight management research.
Key Specifications
- Type: Triple receptor agonist (GLP-1/GIP/Glucagon)
- Purity: >99% (HPLC verified)
- Appearance: White lyophilized powder
- Storage: 2-8°C (lyophilized)
- Classification: Research peptide
Research Applications
- Multi-receptor metabolic pharmacology
- Obesity and weight management mechanisms
- Energy expenditure and thermogenesis
- Glucose and lipid metabolism integration
- Comparative incretin biology
Frequently Asked Questions
What makes Retatrutide different from single or dual agonists?
Retatrutide targets three receptors simultaneously (GLP-1, GIP, and glucagon), providing a unique research tool to study synergistic metabolic effects. The glucagon component may enhance energy expenditure beyond what GLP-1/GIP dual agonism achieves alone.
What purity level does RA101 guarantee?
All Retatrutide batches are verified at >99% purity through independent third-party HPLC and mass spectrometry analysis.
Reviews
There are no reviews yet.